Group 1 - The application of artificial intelligence (AI) technology across the entire energy production, consumption, and management chain is expected to significantly enhance energy efficiency and accelerate the transition of traditional high-carbon industries, including the chemical industry, towards green and low-carbon practices [1] - The integration of AI with various fields in the energy sector is seen as a crucial support for promoting green and low-carbon transformation, particularly in areas such as new energy consumption and smart energy use [1] - The Chinese Academy of Sciences plans to deepen collaboration with various sectors to foster innovation through interdisciplinary and cross-field integration, aiming to leverage AI for low-carbon energy development [1] Group 2 - Huawei is advancing the digitalization of energy by merging digital technologies with power electronics to facilitate the low-carbon transition in the industry, exemplified by their smart chemical park solutions implemented in various chemical enterprises [2] - The company has developed intelligent solutions based on AI and ICT technologies for equipment inspection, safety operations, and process optimization, which aim to reduce costs and enhance safety in chemical operations [2] - Huawei intends to continue innovating in areas such as new materials and catalyst development through AI technology, further accelerating the incubation of smart chemical models [2] Group 3 - The traditional development of new chemical technologies typically requires a lengthy process involving multiple stages, often taking over 10 years to establish demonstration plants, highlighting the need for a breakthrough in research paradigms [3] - A team led by an academician from the Chinese Academy of Engineering proposed a dual-driven approach using data and scientific theory to develop a chemical model that addresses the challenges of scaling up from laboratory to factory [3] - The intelligent chemical model 2.0 has established four key platforms for catalytic reactions, process development, pilot scale-up, and factory optimization, providing a new methodology for chemical technology development [3]

Group 1 - The core concept of "new quality productivity" is emerging as a key term in the medical industry, providing scientific guidance for high-quality development [1] - Experts emphasize that new quality productivity in healthcare focuses on technological autonomy, intelligent services, and industrial collaboration, covering innovations from high-end equipment to AI diagnosis and gene therapy [1][2] - The application of new technologies and achievements is reshaping the healthcare ecosystem, aiming to improve patient cure rates and diagnostic convenience [2] Group 2 - AI-driven innovations, such as vertical large models like DeepSeek, are seen as representatives of new quality productivity, significantly accelerating drug discovery and enhancing disease data collection and analysis [2][3] - The introduction of robotic surgery and AI applications in medical imaging is leading to breakthroughs in minimally invasive and precise surgical techniques [3] - The integration of AI in drug development is expected to enhance innovation capabilities and market competitiveness for companies in the biopharmaceutical sector [3] Group 3 - The 2025 Zhongguancun Forum showcased various medical enterprises actively positioning themselves to ascend the value chain and accelerate the formation of new quality productivity [4] - The "Beijing Brain No. 1" brain-computer interface, developed by Beijing Brain Institute and a tech company, has completed human trials and aims to assist speech-impaired patients [4][7] - Innovative drug companies are highlighting their self-developed products, with a focus on new therapies for blood cancers and autoimmune diseases [7] Group 4 - Medical device companies are emphasizing the importance of improving accessibility to innovative medical products, as demonstrated by the Lattice flow-directed mesh stent for treating intracranial aneurysms [8][10] - The Lattice stent has been successfully implemented in various hospitals, allowing for easier procedures and broader access to treatment in remote areas [10] Group 5 - Investors are increasingly optimistic about the new quality productivity in the medical sector, with AI showing significant potential in drug development, clinical diagnosis, and health management [11] - Domestic companies like BeiGene and Legend Biotech are noted for their competitive performance in global trials, reflecting the growing influence of China's new quality productivity [11][13] - The cell and gene therapy fields are expected to see substantial technological advancements in the next 5 to 10 years, attracting investor attention [13]

一场科技盛会，一个观察中国经济的窗口。 一批重大科技成果亮相、100项国际技术交易创新项目揭晓、促成签约金额810亿元……3月27日至31 日，以"新质生产力与全球科技合作"为主题的2025中关村论坛年会在北京举办。来自全球的上千名嘉宾 共聚一堂，共议科技创新培育新质生产力，为全球创新发展提供新思路、新启示。 科技创新是人类社会发展的重要引擎，能够催生新产业、新模式、新动能，是发展新质生产力的核心要 素。数据显示，我国拥有26个全球百强科技创新集群，连续两年位居世界第一；国内发明专利有效量达 到475.6万件，成为世界上首个突破400万件的国家。以科技创新为支撑，我国经济活力涌动，展现出强 大动能和广阔前景。 活力迸发 看改革点燃科技创新"新引擎" 通用智能人"通通"2.0升级亮相，发布通用人工智能综合评测体系"通智测试"，联合乐聚、宇树等多家 人形机器人公司共同发起成立"通智大脑联盟"……2025中关村论坛年会上，北京通用人工智能研究院发 布多项成果。 "依托新型研发机构的优势，我们纵向贯通产学研、横向实现多学科交叉，围绕共同目标形成创新联合 体。"北京通用人工智能研究院院长朱松纯介绍，新型研发机构最大的优 ...

Group 1 - The 2025 Zhongguancun Forum focused on "New Quality Productivity and Global Technological Cooperation," featuring over a hundred high-level activities and attracting more than a thousand global experts and scholars [1] - Aiko Medical showcased its full range of products in the neuro-intervention field, receiving significant attention and recognition from experts and scholars [1] - The Zhongguancun National Independent Innovation Demonstration Zone exhibition highlighted the role of technological innovation in cultivating new quality productivity and providing new ideas for global innovation development [1] Group 2 - Aiko Medical has been invited to the Zhongguancun Forum for two consecutive years to exchange cutting-edge technologies and showcase scientific and technological achievements [2] - The Lattice flow-directed mesh stent, developed by Aiko Medical, is widely used for treating small to medium-sized vertebral artery aneurysms and has the largest approved indication range among similar products [2] - The Lattice stent has a 12-month aneurysm occlusion rate of 91.4% and a stent-related stenosis rate of only 0.8%, significantly outperforming similar products [2] Group 3 - Aiko Medical introduced the Lattice NEXT "no extended head guidewire" flow-directed mesh stent at the forum, expanding its application to treat unruptured saccular or fusiform wide-neck aneurysms in adult patients [3] - The Lattice NEXT design aims to further reduce surgical risks and enhance safety in neuro-intervention procedures [3] Group 4 - Aiko Medical has eight products approved by the NMPA and has filed 132 patent applications, with 73 granted [4] - The Lattice flow-directed mesh stent has been recognized as an "innovative medical device" by the National Medical Products Administration and received expedited approval through a "green channel" [4] - Aiko Medical aims to provide comprehensive innovative solutions for global cerebrovascular disease patients and doctors, fulfilling unmet clinical needs in the field [4]

以下是倡议全文： 南都讯记者宋承翰发自北京3月27日，中关村论坛举行科学促进可持续发展国际论坛，多位与会嘉宾谈 到了当前国际形势对国际科研成果共享的阻碍。论坛末尾发布了《数字科技促进可持续发展北京倡 议》，呼吁政府、国际组织、学术机构、私营部门和社会各界共同合作，通过数字创新，推动实现联合 国2030年可持续发展议程。 数字科技促进可持续发展北京倡议 我们，2025中关村论坛的与会代表，包括来自政府、国际组织、学术机构、私营部门和社会各界的代 表，宣布我们将共同致力于利用数字科技加速可持续发展，积极应对全球性挑战。 我们深刻认识到数字创新的变革潜力，并共同探索大数据、人工智能、遥感技术、物联网等前沿技术的 应用，以推动联合国2030年可持续发展议程及其17项可持续发展目标(SDGs)的实现。 我们的愿景 我们展望一个以数字科技作为强大驱动力的可持续的未来，通过提供清晰、可操作、可衡量的解决方案 来应对紧迫的全球挑战。通过加强科学研究和技术促进可持续发展的全球合作，我们希望赋能所有利益 相关方，利用数字科技建设一个更加公平、韧性的世界。 我们的目标 为实现这一愿景，我们将致力于推动以下目标的实现： 1.推动数字 ...

新京报讯（记者吴婷婷）4月1日，由国家金融监督管理总局北京监管局、北京经济技术开发区共同设立 的"中关村科创金融服务中心（经开区）" 揭牌成立，该科创金融中心将在金融支持科技创新方面先行 先试，为科技创新企业、中小企业提供创新金融服务。 活动中，中国工商银行北京市分行、中国农业银行北京市分行、中国银行北京市分行、中国建设银行北 京市分行、上海浦东发展银行北京分行、北京银行、上海银行北京分行、北京中关村银行8家试点银行 完成入驻签约。当天，共有中国银行、农业银行等试点银行发布首批创新业务31笔，总金额105亿元， 其中已批复授信8笔，授信金额50.5亿元；意向授信23笔，授信金额54.5亿元。 北京经开区相关负责人介绍，未来，中关村科创金融服务中心（经开区）将在三项创新政策的基础上， 不断丰富业务板块，增强协同效应，优化金融服务体系，为科创企业、中小企业提供更丰富的产品选 择、更便利的融资渠道。 编辑 白爽 校对 刘越 中关村科创金融服务中心（经开区），工作人员为企业提供金融服务。新京报记者 李木易 摄 科创金融中心位于北京经开区政务服务中心3层企业服务专区。该中心将充分依托北京经开区科技型企 业资源，发挥入驻 ...

此外，北京银行董事长霍学文、高成投资创始合伙人洪婧、清华大学五道口金融学院副院长张晓燕、欧 中企业联合会会长、瑞士中小企业经济学家恩里克·施耐德(Henrique Schneider) 等专家学者，分享了各 自研究成果及对AI未来的畅想与期盼。围绕"AI的技术创新、商业化与可持续的美好未来"，达晨财智、 明势创投、九合创投、耀途资本、君联资本等深耕科创领域的投资人进行了圆桌对话。 3月31日，由北京市海淀区人民政府主办的2025中关村论坛"人工智能主题日"核心论坛之一"AI未来论 坛：创新·投资·全球化"在北京举行。北京市政府副秘书长许心超、中国银行首席信息官孟茜，海淀区委 常委、副区长马光耀出席活动并致辞，海淀区委副书记杨仁全出席活动。 启明创投创始主管合伙人邝子平在会上表示，人工智能投资前景广阔，在AI2.0时代，人工智能基础设 施投资仍有很大空缺，人工智能应用爆发式增长可期，人工智能应用的投资未来将会多姿多彩。尤其 AI2.0在垂直行业领域与教育、自动驾驶、具身智能、智能硬件等结合是潜力巨大的应用方向。 金沙江创投主管合伙人朱啸虎强调，生成式AI需坚持"应用为王"，建议初创企业充分拥抱开源生态，聚 焦垂 ...

来源：光明网 3月31日，2025年中关村论坛发布多项重磅成果，可持续发展科学卫星1号入选。在中关村论坛——"科 学促进可持续发展国际论坛"期间，中国科学院院士、可持续发展大数据国际研究中心主任郭华东介 绍，作为全球首颗专为联合国2030年可持续发展议程设计的科学卫星，可持续发展科学卫星1号已向全 球104个国家开放超42万景数据，并在城市热岛效应监测、碳排放评估等领域发挥关键作用。 "世界上有很多卫星，比如气象卫星、海洋卫星等，但它们都是观测自然现象的。可持续发展卫星监测 的是人和地球相互作用之后，在地球表面留下的痕迹，从理念上是创新的，从技术上是先进的。"郭华 东介绍，可持续发展科学卫星1号通过监测能够得到城市夜晚九点的图像，从灯光的颜色判断其种类， 从而了解城市能源分布和发展情况。 目前，可持续发展科学卫星1号数据已在多个场景与领域取得应用成果，在城市监测与管理、环境质量 监测、农业与生态、应对自然灾害等诸多方面发挥着重要作用。基于卫星数据的研究已在国际学术期刊 上发表学术论文125篇，内容涵盖"消除贫困""清洁能源""气候行动"等10个可持续发展目标中近20个具 体目标的指标。未来，可持续发展卫星星座 ...

3月31日，为期5天的2025中关村论坛年会圆满闭幕。 "今年中关村论坛年会跟往届最大的变化是什么？"在今年的中关村论坛年会现场，北京青年报记者随机 采访了多名与会人员，有人说更有国际视野，也有人说科技感更强，还有多名受访者认为，今年的中关 村论坛北京味更足。 诞生于2007年的中关村论坛，历经10余年积淀，已成为我国积极参与世界科技创新实践、深度参与全球 科技治理的重要窗口，成为北京科技力量在这个全球性舞台的一次集中展现。 从中国的硅谷到世界的中关村，这是一场悄无声息的蝶变。以"新质生产力与全球科技合作"为主题的 2025中关村论坛年会已经成为引流全球创新和发展，展现北京综合科技实力的一个舞台。开放的中关村 立足北京、辐射全国、链接全球。 中关村国 际创新中心是中关村论坛永久会址（主办方供图） 人工智能的东方叙事 从"一条街道"开始 北京全力推动 人工智能全球创新策源地建设 在今年中关村论坛年会上，机器人随处可见，它们已经成为论坛不可或缺的一分子。"人机共生"的场景 仿佛让你置身于科幻电影。 在石景山首钢中国科幻大会开幕式现场，机器人递过来一杯冲好的咖啡让你感受温暖；从新闻中心前往 会场的路上，一只"通勤赶 ...

艾柯医疗相关负责人介绍，艾柯医疗自主研发的Lattice血流导向密网支架已广泛应用于椎动脉中小型动 脉瘤的治疗，是目前获批适应症范围最大的同类产品。该产品使用钴铬合金材质，并搭载了机械球囊输 送系统和MIROR表面改性等世界首创的新技术，大幅降低了临床医生手术操作难度、缩短了手术时 间、提高了患者治愈率及手术安全性，使颅内动脉瘤治疗进入"自动档"时代。 本次中关村论坛上，艾柯医疗还展示了2025年全新迭代的Lattice NEXT"无延长头端导丝"血流导向密网 支架。基于行业突破性创新设计，Lattice NEXT将支架的适用范围扩大至成人患者颈内动脉与椎动脉未 破裂的囊状或梭状的宽颈动脉瘤的治疗，实现对神经介入领域的进一步突破深耕。同时，也进一步降低 了手术风险，提高了手术安全性。 来源：环球网 3月31日，2025中关村论坛年会圆满闭幕。作为本次论坛的重要配套活动，中关村国家自主创新示范区 展示中心常设展重装亮相。艾柯医疗携神经介入领域全线产品亮相该展区，这是企业连续第二年受邀参 展。通过此次国际科技交流平台，艾柯医疗全面展示了中国企业在神经介入领域的创新突破。 艾柯医疗方面表示，正努力为全球脑血管病患者 ...